3  2.3  Description of the services LOT 2: Assessment of COVID-19 vaccine effectiveness  among healthcare workers .........................................................................................18  2.3.1  Scope of the services in LOT 2 .....................................................................18  2.3.2  Place of performance and number of meetings of LOT 2 ...........................19  2.3.3  Summary table of tasks, deliverables, quality requirements and timelines in  LOT 2 ............................................................................................................19  2.4  Description of the services LOT 3: COVID-19 vaccine-related studies in long-term care  facilities .......................................................................................................................19  2.4.1  Scope of the services in LOT 3 .....................................................................19  2.4.2  Place of performance and number of meetings of LOT 3 ...........................19  2.4.3  Summary table of tasks, deliverables, quality requirements and timelines in  LOT 3 ............................................................................................................19  2.5  Description of the services LOT 4: Vaccine effectiveness and impact of COVID-19  vaccines through routinely collected exposure and outcome data using health  registries .....................................................................................................................20  2.5.1  Scope of the services in LOT 4 .....................................................................20  2.5.2  Place of performance and number of meetings of LOT 4 ...........................20  2.5.3  Summary table of tasks, deliverables, quality requirements and timelines in  LOT 4 ............................................................................................................20  2.6  Description of the services LOT 5: Vaccine effectiveness against COVID-19 and  seasonal influenza among patients presenting to primary care physicians in EU/EEA  ....................................................................................................................................21  2.6.1  Scope of the services in LOT 5 .....................................................................21  2.6.2  Place of performance and number of meetings of LOT 5 ...........................22  2.6.3  Summary table of tasks, deliverables, quality requirements and timelines in  LOT 5 ............................................................................................................22  2.7  Intellectual property rights .........................................................................................22  2.8  Moral rights of the authors.........................................................................................23  3  EVALUATION AND AWARD ....................................................................................................23  3.1  Verification of non-exclusion ......................................................................................23  3.2  Selection criteria .........................................................................................................24  3.2.1  Declaration and evidence ............................................................................24 